Allergy Diagnostic Market Analysis 2026

Factors Affecting the Allergy Diagnostic Market Growth

• Variability in lifestyle:

The changes in the lifestyle of the people like the preference for junk food in the diet, smoking, and alcohol consumption among youngsters are the major factors driving the growth of the global allergy diagnostics market. Moreover, food allergies are increasing widely because people are ignoring the healthy diet which is expected to increase the market demand. In 2021, according to data from the Asthma and Allergy Foundation of America about 81 million Americans were diagnosed with allergic rhinitis among which 26% were adults and 19% were children. Therefore, a lack of a healthy diet is leading to an increase in allergies among people which will accelerate the demand for allergy diagnostic products demand.

• Increase in environmental pollution:

Occupational exposure is one of the high-risk variables contributing to chronic respiratory disorders, as does increasing exposure to indoor and outdoor air pollution. Due to increased exposure to environmental toxins from industrial activity and urbanization, allergies are far more common in urban than rural areas.  As per WHO guidelines, more than 75% of people living in urban areas are exposed to air quality levels higher than WHO guidelines limit is a major indicator for the growth of the allergy diagnostic market.

• The rising incidence of allergies is also compounded by the rising awareness of allergic diseases among patients and healthcare professionals

The increase in allergic disorders is a worldwide trend, and it affects people from all walks of life and geographical locations. Allergies are no longer confined to certain regions or groups but are increasingly on the rise globally. The World Health Organization (WHO) estimates that about 30-40% of the world's population has allergic disorders. These diseases vary from respiratory allergy such as asthma and allergic rhinitis to food allergy, contact dermatitis, and insect venom allergy. The prevalence of these diseases has been consistently increasing, and this trend is likely to go on for the next few decades.
Various factors are responsible for the increased incidence of allergies: Rising levels of pollution and global warming have been major contributors to the increased incidence of allergic disorders. For instance, air pollution is responsible for respiratory allergies as it worsens conditions in asthma and allergic rhinitis patients. 
The rising incidence of allergies is also compounded by the rising awareness of allergic diseases among patients and healthcare professionals. As more people go for diagnostic tests to determine their allergens, the demand for allergy diagnostic services keeps on increasing. This demand, in turn, fuels the growth of the allergy diagnostics market as healthcare systems compete to deliver accurate and timely testing for allergic disorders.
July 24, 2023- Allergy Testing, with clinicians prescribing more antibiotics, there have been more reported antibiotic allergies. But less than 10% of patients who think they are penicillin-allergic really are. To be sure, some clinicians are referring patients for allergy testing. An allergist will either perform skin testing, and some are performing oral challenges
(Source- https://www.ncbi.nlm.nih.gov/)

• Advances diagnostic technologies have enhanced the accuracy and speed and significant advanced technologies in allergic Diagnostic 

In allergy diagnostic technologies that have transformed the diagnosis and management of allergies. These advances have enhanced the accuracy, speed, and accessibility of allergy testing, hence enhanced patient outcomes and driving market expansion. Some of the most significant technological advances in allergy diagnostics are:
Component-Resolved Diagnostics (CRD) are the classical allergy tests, including skin prick tests and blood tests for the total level of IgE, give an overview of a subject's allergic reaction. However, the above tests do not necessarily give comprehensive information on which particular allergen(s) have triggered the reaction. CRD, by contrast, determines which specific proteins (components) of an allergen stimulate the immune reaction. For instance, CRD is able to differentiate between various kinds of pollen or determine the proteins in peanuts that trigger allergies. With more detailed information, CRD allows for more precise diagnosis and tailored treatment plans.
Artificial Intelligence (AI) Integration are AI technologies are being integrated into allergy diagnostics to enhance the accuracy and speed of interpretation. Machine learning algorithms can analyze vast amounts of data from allergy tests, helping clinicians make faster and more accurate diagnoses. For instance, 2024 Aug 15, Artificial intelligence in the transition of allergy: a valuable tool from childhood to adulthood, AI can identify patterns in blood test results, predict allergy severity, and even suggest personalized treatment plans. As AI develops further, it has the potential to make allergy testing and management as a whole more efficient, opening it up to healthcare providers and patients alike.
(Source- https://pmc.ncbi.nlm.nih.gov/)
 

Restraining Factors for Allergy Diagnostic Market

• The extravagant cost associated with allergy diagnostics instruments:

Various allergy diagnostic instruments like luminometers, immunoassay analyzers, scanners, blot analyzers, and ELISA analyzers are timely updated by market players. These instruments are equipped with advanced facilities and features, they possess high costs. For instance, ELISA analyzers can cost up to USD 15000, hence due to the higher cost of these instruments, the growth of the allergy diagnostic market is expected to restrain.

• High Costs of Testing one of the main constraints in the allergy diagnostics market 

The high cost may restrict access to diagnostic services required, particularly among those without extensive health insurance or in lower-income communities.
Causes of High Expenses are- Sophisticated Technology are tests that employ state-of-the-art technology, i.e., CRD and multiplex assays, tend to use high-end equipment and highly skilled staff. Such tests tend to be more costly than conventional allergy tests because of the complexity of methods involved. For instance, CRD detects unique proteins in allergens, which demands superior laboratory facilities and materials at greater expense.
In certain situations, the results of allergy tests must be interpreted by skilled immunologists or allergists. Such a high level of expertise is generally charged with higher consultation fees, thus again piling costs on patients. Even follow-up tests or treatments would be required, which will add further cost to the diagnosis and treatment of allergies.
In most areas, especially rural or developing regions, the expense of allergy testing can be expensive. Even simple allergy tests might not be accessible because there is limited healthcare infrastructure. This inequity forms a huge gap to diagnosis and treatment for patients in these regions, causing delayed or inappropriate control of allergic diseases.
 

Impact of the COVID-19 pandemic on the Allergy Diagnostic Market:

Due to the COVID outbreak worldwide, there was a negative impact on the allergy diagnostic market. Most allergy illnesses did not require immediate diagnosis since the affected people had established action plans for managing acute episodes and avoiding potential environmental triggers. However, diagnostic procedures were restarted as soon as the pandemic was under control. Telemedicine is preferred by various allergists for treating asthma and rhinitis during the COVID-19 pandemic at a higher rate. For allergic severe conditions like anaphylaxis and hereditary angioedema, face-to-face interviews were recommended in Turkey. Australia reduced the number of outpatient clinics, and face-to-face consultations for urgent patients with rheumatological disorders and switched approximately 80% of outpatient visits to telemedicine.

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Allergy Diagnostic Market is witnessing significant growth in the near future.

In 2023, the Consumables segment accounted for noticeable share of global Allergy Diagnostic Market and is projected to experience significant growth in the near future.

The Academic Research Institutes segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Thermo Fisher Scientific (US) , Danaher (US) and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions